CYBERKNIFE® TREATMENT OF METASTATIC MALIGNANT MELANOMA AS PART OF A MULTIMODALITY THERAPY: A CASE REPORT

Autor:	Xiaodong Wu, Irene Monterroso, Fahed Fayed, James G. Schwade, William T. Brown, James M. Hevezi
Rok vydání:	2011
Předmět:	Oncology medicine.medical_specialty business.industry General Engineering Disease Multimodality Therapy Systemic therapy Metastatic malignant melanoma Cyberknife Internal medicine medicine Overall survival Robotic radiosurgery business Median survival
Zdroj:	Cureus.
ISSN:	2168-8184
DOI:	10.7759/cureus.27
Popis:	Metastatic malignant melanoma is an incurable disease with a median survival of 8.5 months and a probability of surviving five years after the diagnosis of less than 5%. To date, no systemic therapy has meaningfully changed these survival end points. A case of metastatic melanoma treated with combined modalities including image-guided robotic radiosurgery with CyberKnife® (Accuray Incorporated, Sunnyvale, CA, USA), and has an overall survival of 14 years is presented.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69b221583d993b152ac7a5e6f98c2923 https://doi.org/10.7759/cureus.27 Zobrazit plný text záznamu